$3.43
-0.54-13.71%
Last update: Nov 9, 4:00 PM
Passage Bio Inc
PASGNASDAQ
The average analyst price target for Passage Bio is $14, 321.7% above the current price. Of 8 analysts, 5 rate it Buy and 3 Hold. Targets range from $7 to $23. The latest change came on Apr 21, 2026, when TD Cowen downgraded Passage Bio from Buy to Hold.
Price Target Range — 11 Quarters
Analyst Consensus — 8 Analysts
Rating Trend — Last 9 Months
